A

Axogen, Inc. (AXGN)

NCM – Real vaqt narxi. Valyuta: USD

49.09

+0.61 (1.26%)

Bozor ochiq: Aug 12, 2026, 1:51 PM EDT

48.48

0.00 (0.00%)

Oldingi bozordan keyin: Aug 11, 2026, 7:34 PM EDT

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz haqimizda

Biz bilan bog'lanish

[email protected]

Bizni kuzating

Barcha huquqlar himoyalangan.

Foydalanish shartlari

A

Axogen, Inc. (AXGN)

NCM – Real vaqt narxi. Valyuta: USD

49.09

+0.61 (1.26%)

Bozor ochiq: Aug 12, 2026, 1:51 PM EDT

48.48

0.00 (0.00%)

Oldingi bozordan keyin: Aug 11, 2026, 7:34 PM EDT

03.08.2026

Axogen: The Regulatory Moat Is Becoming A Commercial Flywheel

Axogen is transforming from a niche tissue supplier into a comprehensive nerve care platform, underpinned by FDA approval, stronger reimbursement, and expanding clinical evidence. Q2 2026 revenue grew 23.1% to $69.7M, with raised full-year guidance and strong elective market traction, though gross margin declined due to product mix and biologic costs. Avance's FDA biologic approval grants 12 years of exclusivity, regulatory credibility, and improved payer coverage, positioning AXGN as a category leader with significant market opportunity.

Videolar

No Data

There is no data to display

Search stocks

Axogen, Inc. (AXGN)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Axogen, Inc. (AXGN)

Axogen: The Regulatory Moat Is Becoming A Commercial Flywheel

Videolar

No Data